| Target Price | $5.10 |
| Price | $6.28 |
| Deviation |
18.79%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Aethlon Medical, Inc. 2027 .
The average Aethlon Medical, Inc. target price is $5.10.
This is
18.79%
register free of charge
$5.25
16.40%
register free of charge
$5.05
19.59%
register free of charge
|
|
| A rating was issued by 7 analysts: 0 Analysts recommend Aethlon Medical, Inc. to buy, 4 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Aethlon Medical, Inc. stock has an average upside potential 2027 of
18.79%
register free of charge
|
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| P/E | negative |
5 Analysts have issued a Aethlon Medical, Inc. forecast for earnings per share. The average Aethlon Medical, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Aethlon Medical, Inc....
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 14 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 10 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Feb 19 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 30 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 15 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 14 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 10 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Feb 19 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 30 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 15 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


